![Eric Carter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eric Carter
Director/Board Member at AEON BIOPHARMA, INC.
Net worth: - $ as of 30/05/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert Emanuele | M | 69 |
Visgenx, Inc.
![]() Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | - |
Laurent Fischer | M | 60 | 4 years | |
Robert Palmisano | M | 79 |
AEON Biopharma Sub, Inc.
![]() AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
Peter Reynolds | M | 66 |
AEON Biopharma Sub, Inc.
![]() AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 2 years |
Scott Whitcup | M | 64 | 20 years | |
Santosh Vetticaden | M | 65 |
Visgenx, Inc.
![]() Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | - |
Shelley Thunen | F | 71 |
AEON Biopharma Sub, Inc.
![]() AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
Marc Forth | M | 53 | 5 years | |
Peter Soparkar | M | 53 | 5 years | |
David Pyott | M | 70 |
Bioniz Therapeutics, Inc.
![]() Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Bioniz Therapeutics, Inc. operates as a biopharmaceutical firm. The firm engages in the development of peptide therapeutics that selectively and simultaneously inhibit multiple cytokines for the treatment of immune diseases and cancer. The company was founded by Yutaka Tagaya and Nazli Azimi in 2009 and is headquartered in Irvine, CA. | 8 years |
Alex Wilson | M | 38 | 3 years | |
Chad Oh | M | 66 |
AEON Biopharma Sub, Inc.
![]() AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 3 years |
Heikki Jouttijärvi | M | - | 4 years | |
Dawn Svoronos | F | 70 | 4 years | |
William Pedranti | M | - |
Visgenx, Inc.
![]() Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | 1 years |
Reed Tuckson | M | 73 | 3 years | |
Mark Lupher | M | 53 | 5 years | |
Richard Taketa | M | 52 |
AEON Biopharma Sub, Inc.
![]() AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 6 years |
Jim Scopa | M | 65 | 5 years | |
Simone Blank | F | 61 |
AEON Biopharma Sub, Inc.
![]() AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 8 years |
Jost Fischer | M | 69 |
AEON Biopharma Sub, Inc.
![]() AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 7 years |
Thomas Meier | M | 62 |
Visgenx, Inc.
![]() Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | 2 years |
Thomas Meier | M | - |
Visgenx, Inc.
![]() Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | - |
Dena House | F | - | 5 years | |
Darren O Brien | M | 48 |
AEON Biopharma Sub, Inc.
![]() AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
Elaine Heron | M | 76 |
Visgenx, Inc.
![]() Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | - |
Arthur Becker | M | 74 |
Visgenx, Inc.
![]() Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | - |
Chris Carr | M | 54 |
AEON Biopharma Sub, Inc.
![]() AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 5 years |
Adelbert L. Stagg | M | 77 |
AEON Biopharma Sub, Inc.
![]() AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 5 years |
Dorota Skowronska-Krawczyk | M | - |
Visgenx, Inc.
![]() Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | - |
Daniel L. Chao | M | - |
Visgenx, Inc.
![]() Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | - |
Ed Inal | M | - |
AEON Biopharma Sub, Inc.
![]() AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 2 years |
Bill Tan | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Mark Litton | M | 56 | 14 years | |
Paul Cleveland | M | 67 | 4 years | |
Amber Salzman | M | 62 | 2 years | |
Herb Boyer | M | 87 | 19 years | |
Jennifer Cheng | M | 51 | 4 years | |
Jeremy Charles Green | M | 49 | - | |
Ambrose Bailey | M | 60 | - | |
Christopher J. DeRespino | M | 43 | - | |
Steven Schwartz | M | 62 | 11 years | |
Vivid Sehgal | M | 56 | 8 years | |
Robert Azelby | M | 56 | 1 years | |
Leonard Schaeffer | M | 78 | 18 years | |
Melissa Yeager | F | - | 1 years | |
Peter John McDonnell | M | 66 | 7 years | |
David Berk | M | 45 | 6 years | |
Rekha Hemrajani | F | 54 | 2 years | |
Linda C. Wase | M | - |
KP Pharmaceuticals LLC
![]() KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology KP Pharmaceuticals LLC is a pharmaceuticals company which develops, manufactures, markets and sells branded prescription pharmaceutical products. The company was founded by John M. Gregory, Randal J. Kirk, Joseph R. Gregory, Jefferson J. Gregory and James E. Gregory in 1993 and is is headquartered in Bristol, TN. | 4 years |
Angela Thedinga | F | 42 | 2 years | |
Katherine Bock | F | - | 1 years | |
Charles McDermott | M | 52 | 8 years | |
Samuel Barone | M | 51 | 3 years | |
Maria Hilado | F | 59 | 4 years | |
Robert Alexander Ingram | M | 81 | 7 years | |
Kleanthis Xanthopoulos | M | 66 |
Bioniz Therapeutics, Inc.
![]() Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Bioniz Therapeutics, Inc. operates as a biopharmaceutical firm. The firm engages in the development of peptide therapeutics that selectively and simultaneously inhibit multiple cytokines for the treatment of immune diseases and cancer. The company was founded by Yutaka Tagaya and Nazli Azimi in 2009 and is headquartered in Irvine, CA. | 1 years |
Alexandre Kaoukhov | M | - |
Bioniz Therapeutics, Inc.
![]() Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Bioniz Therapeutics, Inc. operates as a biopharmaceutical firm. The firm engages in the development of peptide therapeutics that selectively and simultaneously inhibit multiple cytokines for the treatment of immune diseases and cancer. The company was founded by Yutaka Tagaya and Nazli Azimi in 2009 and is headquartered in Irvine, CA. | 9 years |
Samuel Gesten | M | 62 | 2 years | |
Mitchell Finer | M | 65 | 13 years | |
Philippe Schaison | M | 62 | 3 years | |
Stephen J. Ryan | M | 83 | 11 years | |
Myesha Lacy | F | - | - | |
Dawn Hudson | F | 66 | 6 years | |
Stephen M. Dow | M | 68 | 13 years | |
Alan Montgomery | M | 70 | 9 years | |
Nancy Grygiel | F | 56 | 4 years | |
Linda Neuman | M | 59 | 1 years | |
John Harlow | M | - |
KP Pharmaceuticals LLC
![]() KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology KP Pharmaceuticals LLC is a pharmaceuticals company which develops, manufactures, markets and sells branded prescription pharmaceutical products. The company was founded by John M. Gregory, Randal J. Kirk, Joseph R. Gregory, Jefferson J. Gregory and James E. Gregory in 1993 and is is headquartered in Bristol, TN. | 2 years |
Ashwin K. Agarwal | M | - | 2 years | |
Lars Kielhorn | M | - | 3 years | |
Carlos Campoy | M | 60 | 1 years | |
Gabriella Szekely | M | - | 7 years | |
Thomas Leung | M | 43 | 2 years | |
Jane Wolf | F | - | 1 years | |
Christopher Nardo | M | 59 | 5 years | |
Alisa Lask | F | 53 | 3 years | |
Aaron Osborne | M | 50 | 2 years | |
Timothy Kirk Andrews | M | 45 | 5 years | |
F. Ball | M | 68 | 16 years | |
David Moatazedi | M | 46 | 5 years | |
Suketu D. Desai | M | 59 | 1 years | |
Raymond Diradoorian | M | 66 | 34 years | |
Timothy Proctor | M | 74 | 2 years | |
Graham Cooper | M | 54 |
Bioniz Therapeutics, Inc.
![]() Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Bioniz Therapeutics, Inc. operates as a biopharmaceutical firm. The firm engages in the development of peptide therapeutics that selectively and simultaneously inhibit multiple cytokines for the treatment of immune diseases and cancer. The company was founded by Yutaka Tagaya and Nazli Azimi in 2009 and is headquartered in Irvine, CA. | - |
Jonathan Wesley Porter | M | 54 | 2 years | |
Henri A. Termeer | M | 78 | 1 years | |
R. Charles Moyer | M | 78 |
KP Pharmaceuticals LLC
![]() KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology KP Pharmaceuticals LLC is a pharmaceuticals company which develops, manufactures, markets and sells branded prescription pharmaceutical products. The company was founded by John M. Gregory, Randal J. Kirk, Joseph R. Gregory, Jefferson J. Gregory and James E. Gregory in 1993 and is is headquartered in Bristol, TN. | 11 years |
John J. Howarth | M | - |
KP Pharmaceuticals LLC
![]() KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology KP Pharmaceuticals LLC is a pharmaceuticals company which develops, manufactures, markets and sells branded prescription pharmaceutical products. The company was founded by John M. Gregory, Randal J. Kirk, Joseph R. Gregory, Jefferson J. Gregory and James E. Gregory in 1993 and is is headquartered in Bristol, TN. | - |
John Knighton | M | 45 |
KP Pharmaceuticals LLC
![]() KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology KP Pharmaceuticals LLC is a pharmaceuticals company which develops, manufactures, markets and sells branded prescription pharmaceutical products. The company was founded by John M. Gregory, Randal J. Kirk, Joseph R. Gregory, Jefferson J. Gregory and James E. Gregory in 1993 and is is headquartered in Bristol, TN. | 3 years |
Ian Bell | M | 54 | 9 years | |
Tyler Roberts | M | - |
KP Pharmaceuticals LLC
![]() KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology KP Pharmaceuticals LLC is a pharmaceuticals company which develops, manufactures, markets and sells branded prescription pharmaceutical products. The company was founded by John M. Gregory, Randal J. Kirk, Joseph R. Gregory, Jefferson J. Gregory and James E. Gregory in 1993 and is is headquartered in Bristol, TN. | 2 years |
Kimberly D. Hunsicker | F | - | 2 years | |
Karen Smith | M | 56 | 4 years | |
Dennis Huang | M | 59 | 7 years | |
Ryan Brown | M | 46 | 1 years | |
Catherine Turkel | M | 63 | 17 years | |
Paul L. Jenkinson | M | 64 | 9 years | |
Lori Lyons-Williams | F | 46 | 2 years | |
Clifton Chang | M | - | 6 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Eric Carter
- Personal Network